A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (greater than or equal to 16 to 80 Years Old) With Partial Onset Seizures

Trial Profile

A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (greater than or equal to 16 to 80 Years Old) With Partial Onset Seizures

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jun 2017

At a glance

  • Drugs Brivaracetam (Primary)
  • Indications Partial epilepsies
  • Focus Registrational; Therapeutic Use
  • Acronyms BRITE
  • Sponsors UCB
  • Most Recent Events

    • 18 Dec 2016 Results of pooled analysis of three phase III studies including this study published in the Epilepsia
    • 22 Jun 2016 Results (pooled analysis of this and other two studies) assessing efficacy, safety, and tolerability of adjunctive brivaracetam published in the Neurology.
    • 21 Apr 2016 Pooled analysis (N=1160) assessing efficacy of brivaracetam as adjunctive therapy in partial onset seizures of 3 studies (NCT00490035, NCT00464269, NCT01261325) were presented at the 68th Annual Meeting of the American Academy of Neurology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top